Empagliflozin confers kidney-protective benefits after acute MI
By
Haymarket Media
Sep 09, 2024
A reduced risk was seen for total hospitalizations for heart failure, total adverse events of heart failure or all-cause mortality.
Triglyceride-glucose index independently linked to all-cause mortality
Jun 21, 2024
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.